Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CytRx Corp (NASDAQ:CYTR)

0.3955
Delayed Data
As of Mar 22
 -0.0123 / -3.02%
Today’s Change
0.36
Today|||52-Week Range
3.66
+6.26%
Year-to-Date
No recent news for CytRx Corp.

Today’s Trading

Previous close0.41
Today’s open0.42
Day’s range0.38 - 0.42
Volume1,031,827
Average volume (3 months)1,382,567
Market cap$47.8M
Dividend yield--
Data as of 3:59pm ET, 03/22/2017

Growth & Valuation

Earnings growth (last year)+35.05%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+100.00%
P/E ratioNM
Price/Sales150.86
Price/Book2.10

Competitors

 Today’s
change
Today’s
% change
PTIEPain Therapeutics In...+0.04+4.04%
CLBSCaladrius Bioscience...-0.29-5.62%
PIPPharmAthene Inc-0.00-0.23%
MTFBMotif Bio PLC-0.03-0.48%
Data as of 4:02pm ET, 03/22/2017

Financials

Last reporting dateMarch 15, 2017
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$200.0K
Annual profit (last year)-$50.8M
Net profit margin-25,385.61%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Steven A. Kriegsman
Chief Operating &
Medical Officer
Daniel J. Levitt
Corporate headquarters
Los Angeles, California

Forecasts


Search for Jobs